Show simple item record

dc.contributor.authorSushentsev, Nikita
dc.contributor.authorMcLean, Mary A
dc.contributor.authorWarren, Anne
dc.contributor.authorBenjamin, Arnold JV
dc.contributor.authorBrodie, Cara
dc.contributor.authorFrary, Amy
dc.contributor.authorGill, Andrew
dc.contributor.authorJones, Julia
dc.contributor.authorKaggie, Joshua
dc.contributor.authorLamb, Benjamin W
dc.contributor.authorLocke, Matthew J
dc.contributor.authorMiller, Jodi L
dc.contributor.authorMills, Ian G
dc.contributor.authorPriest, Andrew N
dc.contributor.authorRobb, Fraser JL
dc.contributor.authorShah, Nimish
dc.contributor.authorSchulte, Rolf S
dc.contributor.authorGraves, Martin J
dc.contributor.authorGnanapragasam, Vincent
dc.contributor.authorBrindle, Kevin
dc.contributor.authorBarrett, Tristan
dc.contributor.authorGallagher, Ferdia
dc.date.accessioned2021-12-08T00:30:16Z
dc.date.available2021-12-08T00:30:16Z
dc.identifier.issn2041-1723
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/331260
dc.description.abstractHyperpolarised magnetic resonance imaging (HP-13C-MRI) is an emerging clinical technique to detect [1-13C]lactate production in prostate cancer (PCa) following intravenous injection of hyperpolarised [1-13C]pyruvate. Here we differentiate clinically-significant PCa from indolent disease in a low/intermediate-risk population by correlating [1-13C]lactate labelling on MRI with the percentage of Gleason pattern 4 (%GP4) disease. Using immunohistochemistry and spatial transcriptomics, we show that HP-13C-MRI predominantly measures metabolism in the epithelial compartment of the tumour, rather than the stroma. MRI-derived tumour [1-13C]lactate labelling correlated with epithelial mRNA expression of the enzyme lactate dehydrogenase (LDHA and LDHB combined), and the ratio of lactate transporter expression between the epithelial and stromal compartments (epithelium-to-stroma MCT4). We observe similar changes in MCT4, LDHA, and LDHB between tumours with primary Gleason patterns 3 and 4 in an independent TCGA cohort. Therefore, HP-13C-MRI can metabolically phenotype clinically significant disease based on underlying metabolic differences in the epithelial and stromal tumour compartments.
dc.description.sponsorshipProstate Cancer UK (PCUK; Grant PA14-012) and Cancer Research UK (CRUK; Grants C19212/A27150, C19212/A16628).
dc.publisherNature Research
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleHyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
dc.typeArticle
dc.publisher.departmentDepartment of Radiology
dc.publisher.departmentDepartment of Biochemistry
dc.date.updated2021-12-06T09:00:30Z
prism.publicationNameNature Communications
dc.identifier.doi10.17863/CAM.78706
dcterms.dateAccepted2021-12-02
rioxxterms.versionAM
dc.contributor.orcidWarren, Anne [0000-0002-1170-7867]
dc.contributor.orcidFrary, Amy [0000-0002-4373-3517]
dc.contributor.orcidGill, Andrew [0000-0002-9287-9563]
dc.contributor.orcidKaggie, Joshua [0000-0001-6706-3442]
dc.contributor.orcidGnanapragasam, Vincent [0000-0003-4722-4207]
dc.contributor.orcidBrindle, Kevin [0000-0003-3883-6287]
dc.contributor.orcidBarrett, Tristan [0000-0002-1180-1474]
dc.contributor.orcidGallagher, Ferdia [0000-0003-4784-5230]
rioxxterms.typeJournal Article/Review
cam.orpheus.counter15*
cam.depositDate2021-12-06
pubs.licence-identifierapollo-deposit-licence-2-1
pubs.licence-display-nameApollo Repository Deposit Licence Agreement
rioxxterms.freetoread.startdate2024-12-07


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International